INSUBCONTINENT EXCLUSIVE:
Visakhapatnam: The Unit Approval Committee (UAC) of Visakhapatnam Unique Economic Zone (VSEZ) chaired by Advancement Commissioner A
Rama Mohan Reddy has approved several units located on VSEZ properties in the city.The zone validated propositions of Dr Reddy's Laboratory
for making 10.5 lakh remdesivir vials, which will enter markets in August
It likewise later on approved the proposals for making anti-cancer drug 'Eribulin Mesylate' injection with yearly capability of 1.28 lakh
vials from Duvvada unit of Gland Pharma, which will in turn make an extra net foreign exchange to the tune of Rs 5 crore per year
The UAC has actually given its nod for Constel Production for making jewellery at Duvvada
It is basically into laser cutting and polishing of synthetic or laboratory-grown diamonds, and will earn an additional foreign exchange of
Rs 2.75 crore.Among others, the Advancement Commissioner stated, the committee accorded approval to Salora Active Pharma Sciences in APSEZ
Atchutapuram for making intermediates of Favipiravir, Uridine intermediate of Molnufiravir of 8,000 kgs each month to Laurus Labs,
Both are necessary Covid drugs
The UAC gave approvals for of Fluticasone nasal spray, Prednisone tablets of different does in favour of Dr Reddy's, Srikakulam,
Amphotericin bulk, an API, in favour of Hetero, and for manufacture Fosravuconazole L Lysine Ethanolate, both antifungal medications,
besides different other intermediates to Aragen Life Sciences Pvt Ltd., in Ramky Pharma for 1 MT
The UAC likewise permitted Divis Laboratories Ltd to go in for making of Sacubitril Valsartan Sodium Hydrate, a drug to be utilized in
